Atlas Trials

Purpura, Thrombocytopaenic, Idiopathic

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Purpura, Thrombocytopaenic, Idiopathic

RecordFirmDate
A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia. (NCT01440361)GlaxoSmithKline2013-03-01
Drug Use Investigation for REVOLADE (ITP) (NCT01416311)Novartis Pharmaceuticals2010-12-21
A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) (NCT01098487)GlaxoSmithKline2010-05-01
Promacta Pregnancy Registry (NCT01064336)GlaxoSmithKline2010-03-01
Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food Effect (NCT01072162)GlaxoSmithKline2010-01-12
Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP) (NCT00908037)GlaxoSmithKline2009-09-30
Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag (NCT00688272)GlaxoSmithKline2008-06-02
Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT) (NCT00424177)GlaxoSmithKline2007-03-01
LENS - Long-term Eltrombopag Observational Study (NCT00643929)GlaxoSmithKline2007-02-01
RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag (NCT00370331)GlaxoSmithKline2006-11-01
Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment (NCT00442871)GlaxoSmithKline2006-09-28
Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment (NCT00359463)GlaxoSmithKline2006-04-18
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP) (NCT00102739)GlaxoSmithKline2005-02-01

Track Purpura, Thrombocytopaenic, Idiopathic automatically

Every clearance here is in the API, with alerts when new ones post.